Literature DB >> 30158276

The broad spectrum of lung diseases in primary antibody deficiencies.

Francesco Cinetto1,2, Riccardo Scarpa1,2, Marcello Rattazzi1,2, Carlo Agostini1,2.   

Abstract

Human primary immunodeficiency diseases (PIDs) represent a heterogeneous group of more than 350 disorders. They are rare diseases, but their global incidence is more relevant than generally thought. The underlying defect may involve different branches of the innate and/or adaptive immune response. Thus, the clinical picture may range from severe phenotypes characterised by a broad spectrum of infections to milder infectious phenotypes due to more selective (and frequent) immune defects. Moreover, infections may not be the main clinical features in some PIDs that might present with autoimmunity, auto-inflammation and/or cancer. Primary antibody deficiencies (PADs) represent a small percentage of the known PIDs but they are the most frequently diagnosed, particularly in adulthood. Common variable immunodeficiency (CVID) is the most prevalent symptomatic PAD.PAD patients share a significant susceptibility to respiratory diseases that represent a relevant cause of morbidity and mortality. Pulmonary complications include acute and chronic infection-related diseases, such as pneumonia and bronchiectasis. They also include immune-mediated interstitial lung diseases, such as granulomatous-lymphocytic interstitial lung disease (GLILD) and cancer. Herein we will discuss the main pulmonary manifestations of PADs, the associated functional and imaging findings, and the relevant role of pulmonologists and chest radiologists in diagnosis and surveillance.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30158276     DOI: 10.1183/16000617.0019-2018

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  13 in total

1.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry.

Authors:  Meera Patrawala; Ying Cui; Limin Peng; Ramsay L Fuleihan; Elizabeth K Garabedian; Kiran Patel; Lokesh Guglani
Journal:  J Clin Immunol       Date:  2020-01-09       Impact factor: 8.317

Review 2.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

3.  Evaluation of pulmonary findings in patients with humoral immunodeficiency.

Authors:  Zuhal Karalı; Yasin Karalı; Şükrü Çekiç; Zeynep Yazıcı; Yakup Canıtez; Nihat Sapan; Sara Şebnem Kılıç Gültekin
Journal:  Turk Pediatri Ars       Date:  2020-06-19

4.  Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study.

Authors:  Veronica Pedini; Jacopo Umberto Verga; Irene Terrenato; Denise Menghini; Cristina Mezzanotte; Maria Giovanna Danieli
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-26       Impact factor: 3.406

5.  Primary Immunodeficiencies in a Mesoregion of São Paulo, Brazil: Epidemiologic, Clinical, and Geospatial Approach.

Authors:  Denise Helena Boton Pereira; Lívia Souza Primo; Giovana Pelizari; Edilson Flores; Dewton de Moraes-Vasconcelos; Antonio Condino-Neto; Luiz Euribel Prestes-Carneiro
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

6.  Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age.

Authors:  Xiaolei Tang; Huimin Li; Hui Liu; Hui Xu; Haiming Yang; Jinrong Liu; Shunying Zhao
Journal:  Orphanet J Rare Dis       Date:  2020-01-22       Impact factor: 4.123

7.  Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency.

Authors:  Joo Hee Kim; Jae Hyuk Jang; So Hee Lee; Eun Mi Yang; Seung Hun Jang; Ki Suck Jung; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

Review 8.  Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations.

Authors:  Dana Unninayar; Sara J Abdallah; D William Cameron; Juthaporn Cowan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-02

9.  A COVID-19 family cluster with retinitis pigmentosa and hypogammaglobulinemia.

Authors:  Abeer N Alshukairi; Yasser A Aldabbagh; Najla M Sayes; Manal M Al Gethamy; Mohammed G Alghamdi; Zuhair A Rahbeeni; Ashraf Dada
Journal:  Ann Thorac Med       Date:  2022-01-14       Impact factor: 2.219

10.  Interstitial Lung Disease in Children With Selected Primary Immunodeficiency Disorders-A Multicenter Observational Study.

Authors:  Małgorzata Pac; Teresa Bielecka; Katarzyna Grzela; Justyna Komarnicka; Renata Langfort; Sylwia Koltan; Nel Dabrowska-Leonik; Katarzyna Bernat-Sitarz; Maciej Pronicki; Hanna Dmenska; Anna Pituch-Noworolska; Bozena Mikoluc; Barbara Piatosa; Katarzyna Tkaczyk; Ewa Bernatowska; Irena Wojsyk-Banaszak; Katarzyna Krenke
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.